Dry CLIA analyzer ADL-1000

Dry CLIA analyzer ADL-1000

Analysers

Information

The Anbio ADL-1000 is a fully automated, compact, and affordable CLIA analyzer that adopts direct chemiluminescence method based on acridinium ester and works clinically with supporting reagents for qualitative or quantitative testing of analytes in human serum, plasma, whole blood and urine samples, including hormones detection, myocardial disease detection, infectious disease detection, and tumor-related antigens detection. ADL-1000 analyzer and the dry CLlA assays are developed and innovated by Anbio R&D team. With dry assays, it is convenient and cost-efficient for both transport and storage.
Anbio BiotechnologyS1.F50Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitro diagnostics. Our goal is to revolutionize the diagnostics market by personalizing and decentralizing current diagnostic solutions, enabling rapid diagnosis and improving patient prognosis. We achieve this by offering cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (lVD) solutions that are rapid, accessible, and affordable on a global scale. Since its establishment, Anbio has been committed to delivering the most advanced diagnostic solutions while ensuring cost-effectiveness for our customers. Our extensive capabilities in research and development, manufacturing, and global product distribution logistics allowing us to continuously focus on cost reduction while offering a wide range of mature laboratory diagnostics and point-of-care technology (POCT) products. Our product range spans across cancer, cardiovascular conditions, pharmacogenomics, hormones, infectious diseases, inflammation, and drugs of abuse tests.

Log in

See all the content and easy-to-use features by logging in or registering!